Gen-Probe Reports Financial Results for Second Quarter 2009
...tinued growth of the APTIMA Combo 2(R) assay, an amplified nucleic acid test (NAT) for simultaneously detecting Chlamydia trachomatis and Neisseria gonorrhoeae . Sales of our market-leading assay increased based on market share gains on both the Company's semi-automated instrument platform and on the high-th...Spanish prostitutes least likely to use condoms
...d recently in the journal Sexually Transmitted Diseases , show the rate of HIV infection to be 1.8%, that of Chlamydia trachomatis 5.5% and Neisseria gonorrhoeae 0.5%. The only differences were observed in the HIV infection rates, which were significantly higher among the Spanish SWs, at 9.3%. In addition, 49.7...BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
...r testing for Chlamydia and gonorrhea with its BD ProbeTec(TM) Chlamydia trachomatis (CT) Amplified DNA Assay and the BD ProbeTec(TM) Neisseria gonorrhoeae (GC) Amplified DNA Assay. About HandyLab, Inc. HandyLab is dedicated to the development, manufacture and sale of novel molecular diagnostic ...Gen-Probe Reports Financial Results for First Quarter 2009
...d growth of the APTIMA Combo 2(R) assay, an amplified nucleic acid test (NAT) for simultaneously detecting Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC). Sales of this assay increased based on market share gains on both the Company's semi-automated instrument platform and on the high-throughput,...Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
...reptococcus pneumoniae in patients who require initial intravenous therapy and pelvic inflammatory disease due to Chlamydia trachomatis , Neisseria gonorrhoeae , or Mycoplasma hominis in patients who require initial intravenous therapy. If anaerobic microorganisms are suspected of contributing to the infec...Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
...d growth of the APTIMA Combo 2(R) assay, an amplified nucleic acid test (NAT) for simultaneously detecting Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC). Sales of this assay increased based on market share gains on both the Company's semi-automated instrument platform and on the high-throughput,...Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
...nued growth of the APTIMA Combo 2(R) assay, an amplified nucleic acid test (NAT) for simultaneously detecting Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC). Sales of this assay increased based on market share gains on both the Company's semi-automated instrument platform and on the high-throughput, f...Tip sheet for the Annals of Internal Medicine, April 15, 2008, issue
...prescription of domestic generic drugs, they say. 3. Comprehensive Strategy Needed to Control Gonorrhea Epidemic Incidence of Neisseria gonorrhoeae in the United States declined markedly from 1975 to 1997 and has remained relatively stable over the past decade at about 120.9 cases per 100,000 popu...Scientists Concerned About Gonorrhea’s Drug Resistanc
...t (GISP), which covers 26 US cities. The new GISP data shows that among heterosexual men, the percentage of fluoroquinolone-resistant Neisseria gonorrhoeae (QRNG) cases went up 11-fold between 2001 and 2006. In 2001 it was 0.6 percent, and in early 2006 it was 6.7 percent. The treatment options that...Neisseria gonorrhoeae DNA Probe
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...Neisseria gonorrhoeae Antibody
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...Neisseria gonorrhoeae by Amplified Detection (APTIMA)
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...Neisseria gonorrhoeae and Chlamydia trachomatis, DNA Probe
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...Chlamydia trachomatis & Neisseria gonorrhoeae by Amplified Detection (APTIMA), ThinPrep
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...Chlamydia trachomatis & Neisseria gonorrhoeae DNA Probe
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...Chlamydia trachomatis&Neisseria gonorrhoeae by Amplified Detection (APTIMA)
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...Culture, Neisseria gonorrhoeae
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...American Society for Microbiology honors Eric Skaar
...n the molecular mechanisms of antigenic variation in the Gram-negative pathogen Neisseria gonorrhoeae. His research described novel systems used by N. gonorrhoeae to combat the oxidative stress response of the host Dr. Skaar completed his postdoctoral fellowship at the University of Chicago, where he studie...University of Arizona scientist shares in discovery of microbe filaments' power
...s body weight. Pilus retraction forces are an important factor in how N. gonorrhoeae starts an infection. So, who has studied these microbes for more than 20 years, says N. gonorrhoeae communicates with a human cell by pulling on it. These pulling forces pertu...The Bacteria's guide to survival
...hea. By comparing cells infected with normal N. gonorrhoeae to those infected with a mutant strain with defect...s' membranes with their pili. For bacteria like N. gonorrhoeae that pass directly from host to host, the research...n: Howie HL, Glogauer M, So M (2005) The Neisseria gonorrhoeae type IV pilus stimulates mechanosensitive pathways...Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
...nued growth of the APTIMA Combo 2(R) assay, an amplified nucleic acid test (NAT) for simultaneously detecting Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC). Sales of this assay increased based on market share gains on both the Company's semi-automated instrument platform and on the high-throughput, f...Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
...e again led by the APTIMA Combo 2(R) assay, an amplified nucleic acid test (NAT) for simultaneously detecting Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC). Sales of this assay grew based on market share gains on both the Company's semi-automated instrument platform and on the high-throughput, fully ...Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
... E-903, E-907, E-908, E-909: Iclaprim shows good activity against important pathogens such as Chlamydia trachomatis, Legionella pneumophila, Neisseria gonorrhoeae and Enterobacteriaceae. These are involved in various clinical indications. A-804, A-805, A-806: Important Phase I data on intravenous and oral iclap...